*Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh;
†Department of Pathology, Division of Clinical Chemistry, Toxicology and Therapeutic Drug Monitoring Laboratory, University of Pittsburgh Medical Center Presbyterian/Shadyside;
‡Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, Magee Women's Hospital of UPMC, University of Pittsburgh;
§Department of Pathology, School of Medicine, University of Pittsburgh; and
¶Starzl Transplant Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Correspondence: Raman Venkataramanan, PhD, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Salk Hall, Room 7354, Pittsburgh, PA 15213 (e-mail: [email protected])
This work is partially funded by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, HD047905) through the Obstetric Pharmacology Research Center (OPRC) and by the Clinical Pharmacokinetics Laboratory at the School of Pharmacy in the University of Pittsburgh.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
Author Contributions: P. Dodeja: conception or design of the work, acquisition, analysis, or interpretation of data for the work, drafting the work, providing approval for publication of the content, and agreeing to be accountable for all aspects of the work. S.Giannoutsos and S.Caritis: critically revising the manuscript for important intellectual content, providing approval for publication of the content, and agreeing to be accountable for all aspects of the work. R.Venkataramanan: Conception of the work, interpretation of data collected, setting outline for the draft, review final content, and providing approval for publication. All authors have contributed to the manuscript and approved the submitted version.
